ACADIA Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 0.2 | 0.8 | 1.6 | 2.0 | 2.1 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 18.7 | 18.3 | 19.5 | 19.9 | 15.0 |
| Depreciation & Amortization | 0.5 | 0.2 | 0.7 | 0.0 | (0.4) |
| Operating Income | (19.0) | (17.6) | (18.7) | (17.9) | (12.6) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.8 | 1.3 | 1.7 | 1.9 | 1.9 |
| Nonoperating Expenses | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Income Before Taxes | (18.3) | (16.4) | (17.0) | (16.0) | (10.8) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (18.3) | (16.4) | (17.0) | (16.0) | (10.8) |
| Continuing Operations | (18.3) | (16.4) | (17.0) | (16.0) | (10.8) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (18.3) | (16.4) | (17.0) | (16.0) | (10.8) |
| Total Net Income | (18.3) | (16.4) | (17.0) | (16.0) | (10.8) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.50) | (0.44) | (0.46) | (0.44) | (0.28) |
| Dividends per Share | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
